Lifelong Brain-Stimulating Practices Leads to Lower Alzheimer’s Protein Levels
|
By MedImaging International staff writers Posted on 01 Feb 2012 |

Image: PET scans reveal amyloid plaques, which appear as warm colors such as red and orange. The middle scan is from a person with no symptoms of cognitive problems, but with evident levels of amyloid plaque in the brain (Photo courtesy of Susan Landau and William Jagust).
Neuroimaging scans have revealed that individuals with no symptoms of Alzheimer’s who engaged in cognitively stimulating activities throughout their lives had fewer deposits of beta-amyloid, a destructive protein that is major characteristic of the disease.
Whereas earlier studies have implied that engaging in mentally stimulating activities--such as reading, writing, and playing games--may help stave off Alzheimer’s disease later in life, this new study identifies the biologic target at play. This finding could guide future research into effective prevention strategies.
“These findings point to a new way of thinking about how cognitive engagement throughout life affects the brain,” said study lead investigator Dr. William Jagust, a professor with joint appointments at University of California, Berkeley’s (USA) Helen Wills Neuroscience Institute, the School of Public Health and Lawrence Berkeley National Laboratory. “Rather than simply providing resistance to Alzheimer’s, brain-stimulating activities may affect a primary pathological process in the disease. This suggests that cognitive therapies could have significant disease-modifying treatment benefits if applied early enough, before symptoms appear.”
The new study, published January 23, 2012, in the journal Archives of Neurology, places the focus on amyloid--protein fibers folded into tangled plaques that accumulate in the brain. Beta-amyloid is considered the top culprit in the pathology of Alzheimer’s disease; therefore, finding a way to reduce its development has become a major new direction of research.
The researchers noted that the buildup of amyloid can also be influenced by genes and aging-- one-third of people age 60 and over have some amyloid deposits in their brain--but how much reading and writing one does is under each individual’s control. “This is the first time cognitive activity level has been related to amyloid buildup in the brain,” said study lead author Dr. Susan Landau, research scientist at the Helen Wills Neuroscience Institute and the Berkeley Lab. “Amyloid probably starts accumulating many years before symptoms appear. So it’s possible that by the time you have symptoms of Alzheimer’s, like memory problems, there is little that can be done to stop disease progression. The time for intervention may be much sooner, which is why we’re trying to identify whether lifestyle factors might be related to the earliest possible changes.”
The researchers asked 65 healthy, cognitively normal adults aged 60 and over (median age was 76) to rate how frequently they participated in such mentally stilmulating activities as going to the library, reading books or newspapers, and writing letters or email. The questions focused on various points in life from age six to the present.
The participants took part in extensive neuropsychologic testing to evaluate memory and other cognitive functions, and received positron emission tomography (PET) scans at the Berkeley Lab using a new tracer called Pittsburgh compound B that was developed to visualize amyloid. The results of the brain scans of healthy older individuals with various levels of lifetime cognitive activity were compared with those of 10 patients diagnosed with Alzheimer’s disease and 11 healthy individuals in their 20s.
The researchers discovered a significant association between higher levels of cognitive activity over a lifetime and lower levels of beta-amyloid in the PET scans. They analyzed the impact of other factors such as memory function, physical activity, self-rated memory ability, level of education and gender, and found that lifelong cognitive engagement was independently linked to amyloid deposition.
Significantly, the researchers did not find a strong connection between amyloid deposition and levels of current cognitive activity alone. “What our data suggest is that a whole lifetime of engaging in these activities has a bigger effect than being cognitively active just in older age,” said Dr. Landau.
The researchers stressed that the study does not contradict the benefits of jolting brain activity in later years. “There is no downside to cognitive activity. It can only be beneficial, even if for reasons other than reducing amyloid in the brain, including social stimulation and empowerment,” said Dr. Jagust. “And actually, cognitive activity late in life may well turn out to be beneficial for reducing amyloid. We just haven’t found that connection yet.”
Other researchers involved in the study were from the University California (UC) San Francisco’s (USA) Memory and Aging Center and department of neurology, and Rush University Medical Center’s Alzheimer’s Disease Center (Chicago, IL, USA).
Related Links:
University of California, Berkeley
University California, San Francisco
Rush University Medical Center’s Alzheimer’s Disease Center
Whereas earlier studies have implied that engaging in mentally stimulating activities--such as reading, writing, and playing games--may help stave off Alzheimer’s disease later in life, this new study identifies the biologic target at play. This finding could guide future research into effective prevention strategies.
“These findings point to a new way of thinking about how cognitive engagement throughout life affects the brain,” said study lead investigator Dr. William Jagust, a professor with joint appointments at University of California, Berkeley’s (USA) Helen Wills Neuroscience Institute, the School of Public Health and Lawrence Berkeley National Laboratory. “Rather than simply providing resistance to Alzheimer’s, brain-stimulating activities may affect a primary pathological process in the disease. This suggests that cognitive therapies could have significant disease-modifying treatment benefits if applied early enough, before symptoms appear.”
The new study, published January 23, 2012, in the journal Archives of Neurology, places the focus on amyloid--protein fibers folded into tangled plaques that accumulate in the brain. Beta-amyloid is considered the top culprit in the pathology of Alzheimer’s disease; therefore, finding a way to reduce its development has become a major new direction of research.
The researchers noted that the buildup of amyloid can also be influenced by genes and aging-- one-third of people age 60 and over have some amyloid deposits in their brain--but how much reading and writing one does is under each individual’s control. “This is the first time cognitive activity level has been related to amyloid buildup in the brain,” said study lead author Dr. Susan Landau, research scientist at the Helen Wills Neuroscience Institute and the Berkeley Lab. “Amyloid probably starts accumulating many years before symptoms appear. So it’s possible that by the time you have symptoms of Alzheimer’s, like memory problems, there is little that can be done to stop disease progression. The time for intervention may be much sooner, which is why we’re trying to identify whether lifestyle factors might be related to the earliest possible changes.”
The researchers asked 65 healthy, cognitively normal adults aged 60 and over (median age was 76) to rate how frequently they participated in such mentally stilmulating activities as going to the library, reading books or newspapers, and writing letters or email. The questions focused on various points in life from age six to the present.
The participants took part in extensive neuropsychologic testing to evaluate memory and other cognitive functions, and received positron emission tomography (PET) scans at the Berkeley Lab using a new tracer called Pittsburgh compound B that was developed to visualize amyloid. The results of the brain scans of healthy older individuals with various levels of lifetime cognitive activity were compared with those of 10 patients diagnosed with Alzheimer’s disease and 11 healthy individuals in their 20s.
The researchers discovered a significant association between higher levels of cognitive activity over a lifetime and lower levels of beta-amyloid in the PET scans. They analyzed the impact of other factors such as memory function, physical activity, self-rated memory ability, level of education and gender, and found that lifelong cognitive engagement was independently linked to amyloid deposition.
Significantly, the researchers did not find a strong connection between amyloid deposition and levels of current cognitive activity alone. “What our data suggest is that a whole lifetime of engaging in these activities has a bigger effect than being cognitively active just in older age,” said Dr. Landau.
The researchers stressed that the study does not contradict the benefits of jolting brain activity in later years. “There is no downside to cognitive activity. It can only be beneficial, even if for reasons other than reducing amyloid in the brain, including social stimulation and empowerment,” said Dr. Jagust. “And actually, cognitive activity late in life may well turn out to be beneficial for reducing amyloid. We just haven’t found that connection yet.”
Other researchers involved in the study were from the University California (UC) San Francisco’s (USA) Memory and Aging Center and department of neurology, and Rush University Medical Center’s Alzheimer’s Disease Center (Chicago, IL, USA).
Related Links:
University of California, Berkeley
University California, San Francisco
Rush University Medical Center’s Alzheimer’s Disease Center
Latest Nuclear Medicine News
- Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
- Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
- AI Model Predicts Radiation Dose Before Prostate Cancer Therapy
- Vault-Free Radiosurgery Platform Expands Access to Cranial Tumor Care
- MR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
- New Imaging Tool Sheds Light on Tumor Fat Metabolism
- PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
- Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
- Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
Channels
Radiography
view channel
Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read more
AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays
Osteoporosis is a progressive loss of bone density that is often silent until a fracture occurs. Current screening frameworks concentrate on older women and select high-risk groups. Many men, younger adults,... Read moreMRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreGeneral/Advanced Imaging
view channel
AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection
Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read moreNew SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







